Search

    Edition and Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    usreport
    usreport

    FDA approves groundbreaking new drug for pancreatic cancer

    1 hour ago

    The Food and Drug Administration approved a groundbreaking new oral drug for pancreatic patients suffering from the most aggressive form of the disease. Daraxonrasib, which targets a mutation in a gene called KRAS, doubled the survival time in patients who participated in the trial. For more context and news coverage of the most important stories of our day, click here: https://www.nbcnews.com » Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC » Subscribe to Here's the Scoop podcast: https://www.nbcnews.com/heres-the-scoop-daily-podcast » NBC News App: https://apps.nbcnews.com/mobile » Breaking News Alerts: https://link.nbcnews.com/join/5cj/breaking-news-signup?cid=sm_npd_nn_yt_bn-clip_190621 » Visit NBCNews.Com: http://nbcnews.to/ReadNBC » Find NBC News on Facebook: http://nbcnews.to/LikeNBC » Follow NBC News on Twitter: http://nbcnews.to/FollowNBC » Follow NBC News on Instagram: http://nbcnews.to/InstaNBC #medicine #cancer #news
    Click here to Read More
    Previous Article
    Panda Express CEOs share relatable morning routines
    Next Article
    Full Episode: TODAY Show - Aug. 26

    Related Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment